Biotech Values

[dink00]

"Momenta has already sold $292 million of its generic Lovenox, also called enoxaparin, according to analyst Simos Simeonidis of Rodman & Renshaw LLC, an investment bank. He said the company could reap $400 million this quarter as it fills initial orders for the drug. "By any definition, it's a blockbuster," he said. "

400 million this quarter!! That would be awesome.